OncoAlert OncoAlert

✅ TheLancet Commission on #ProstateCancer 
✅DESTINY-PanTumor01
✅Osimertinib+Local tx for brain🧠mets in EGFRm #NSCLC 🫁
✅ASCENT in Triple Negative #BreastCancer 🧪
✅Bilateral Oophorectomy  in BRCA1&2🧬
✅Racialized inequities in live birth after cancer🤰🏾
✅MITO END in Endometrial Cancer
✅Tx Patterns Advanced Urothelial Carcinoma🇺🇸
and more‼️

The OncoAlert Weekly Round Up 🚨Covering April 26- May 1st, 2024
REGISTER at http://OncoAlert360.com OR https://oncoalert.m-pages.com/nhMpwe/oncoalert-newsletter-registration

COVERING
DESTINY-Breast06
Monarch E
US Preventive S Task force #BreastCancer Screen
@US_FDA approval of Tisotumab vedotin
NEO predict-Lung
Pushing Boundaries in ctDNA
StereotactiveRT in oligomet #KidneyCancer
Thromboembolic Risk in #ProstateCancer Patients Treated with PARP Inhibitors
@CancerCareMASCC -  @ASCO Standards and practices in metastatic #Cancer

Special Podcast:
@gu_onc &  @Uromigos at #APCCC24 

What happens when Five Friends initially brought together by oncology meet up in Lugano for #APCCC24..........Magic...thats what!

Join Renu, Declan, Brian, Tom and Gil on this insanely casual and fun conversation on the side 

The OncoAlert  Weekly Round Up
Covering April 19-25, 2024

REGISTER AT http://OncoAlert360.com OR https://oncoalert.m-pages.com/nhMpwe/oncoalert-newsletter-registration

Discussing
ADCs in #LungCancer & #BreastCancer 
Out on 
@Annals_Oncology

https://annalsofoncology.org/article/S0923-7534(24)00108-X/abstract

TILS in #TNBC
https://jamanetwork.com/journals/jama/article-abstract/2816923

TROPION in #BreastCancer
https://ascopubs.org/doi/full/10.1200/JCO.23.01909

DE-REAL in #BreastCancer
https://academic.oup.com/oncolo/article/29/4/303/7444338?login=false

CheckMate9ER in #kidneycancer
https://esmoopen.com/article/S2059-7029(24)00762-2/fulltext#%20

INNOVATED out on 
@ESMO_Open
 

POP RT in #ProstateCancer
https://redjournal.org/article/S0360-3016(24)00439-5/abstract#%20

Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial
https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35333

✅Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma out on @NEJM 
https://www.nejm.org/doi/full/10.1056/NEJMoa2312695#ap0



✅Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial 
https://www.annalsofoncology.org/article/S0923-7534(24)00105-4/fulltext



✅Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(24)00185-X



✅Three-year overall survival outcomes and correlative analyses in patients with non–small-cell lung cancer and high (50-89%) versus very high (≥90%) PD-L1 expression treated with first-line pembrolizumab or cemiplimab
https://www.jtocrr.org/article/S2666-3643(24)00045-6/fulltext



✅The Lancet Breast Cancer Commission
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00747-5/fulltext



✅Top advances of the year: Uterine cancer
https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.35321

The  @OncoAlert RoundUp is Out
Covering April 5th-12th, 2024

REGISTER at http://OncoAlert360.com OR https://oncoalert.m-pages.com/nhMpwe/oncoalert-newsletter-registration

Discussing:
 
@US_FDA
  approval trastuzumab dx
Durvalumab in Small Cell #LungCancer
ALINA  #NSCLC out on 
@NEJM
 
CD70 CART in #KidneyCancer
Adagrasib Cetux in #colorectalcancer 
and more